Abstract:Extramammary Paget’s disease (EMPD) is a rare cutaneous malignancy characterized by its uncertain etiology and metastatic potential. Surgery remains the first-line clinical treatment for EMPD, but the efficacy of radiotherapy and chemotherapy remains to be fully evaluated, and new therapies for EMPD are urgently needed. In this study, we initially screened 815 EMPD patients in the Surveillance, Epidemiology, and End Results (SEER) database and analyzed their clinical features and prognostic factors. Using the dataset from the Genome Sequence Archive (GSA) database, we subsequently conducted weighted gene coexpression network analysis (WGCNA), gene set enrichment analysis (GSEA), gene set variation analysis (GSVA), and immune infiltration analyses, grouping the samples based on EMPD disease status and the levels of ERBB2 expression. The prognostic analysis based on the SEER database identified increased age at diagnosis, distant metastasis, and receipt of radiotherapy as independent risk factors for EMPD. Moreover, our results indicated that patients who received chemotherapy had worse prognoses than those who did not, highlighting the urgent need for novel treatment approaches for EMPD. Functional analysis of the GSA-derived dataset revealed that EMPD tissues were significantly enriched in immune-related pathways compared with normal skin tissues. Compared with those with high ERBB2 expression, tissues with low ERBB2 expression displayed greater immunogenicity and enrichment of immune pathways, particularly those related to B cells. These findings suggest that patients with low ERBB2 expression are likely to benefit from immunotherapy, especially B-cell-related immunotherapy.

Expression and Its Biological Significance of Osteopontin(OPN)and CD44v6 in Extramammary Paget's Disease

Clinical Features and Follow Up Analysis of 19 Patients Wit Extramammary Paget Disease

The Detection and Correlation Analysis of P16 and PCNA in Extramammary Paget′s Disease

The expression of β- catenin and cyclinD1 in extramammary Paget's disease

The expression and correlation analysis of P16 and CDK4 in extramammary Paget’s disease

Immunotherapy May Be More Appropriate for ERBB2 Low-Expressing Extramammary Paget’s Disease Patients: a Prognosis Analysis and Exploration of Targeted Therapy and Immunotherapy of Extramammary Paget’s Disease Patients

Distribution of Cytokeratin5/6(CK5/6) and Cytokeratin14 (CK14) in Extramammary Paget's Disease

Expression of p38 MAPK/NF-κB/cyclin D1 Signaling Pathway in Extramammary Paget's Disease

Expression of Survivin and Human Telomerase Reverse Transcriptase in Extramammary Paget's Disease

133 Distinctive Mirna Expression Profiles in Tissue and Serum of Primary Extramammary Pagets Disease

Pi3k, Rac1 And Ppak1 Are Overexpressed In Extramammary Paget'S Disease

Chemokine Receptors CXCR4 and CXCR7 are Associated with Tumor Aggressiveness and Prognosis in Extramammary Paget Disease.

Expressions of Mucin 1 and 2 in Lesions of Extramammary Paget's Disease

Microarray-based Identification of Differentially Expressed Genes in Extramammary Paget's Disease.

Expressions of Osteopontin and CD44v6 and Their Clinical Significance in Pituitary Adenomas

Expression and Prognostic Significance of Stat5a and E‐cadherin in Extramammary Paget’s Disease

Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients

Implication of Pin1 Expression in Extramammary Paget's Disease

Ultrasound Biomicroscopy and High-Frequency Ultrasound for Evaluating Extramammary Paget Disease with Pathologic Correlation

Clinical and Pathological Characteristics of Extramammary Paget's Disease: Report of 246 Chinese Male Patients.

Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A